<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02908334</url>
  </required_header>
  <id_info>
    <org_study_id>UCSF-Fresno-01</org_study_id>
    <nct_id>NCT02908334</nct_id>
  </id_info>
  <brief_title>Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis</brief_title>
  <official_title>Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study patients will be randomized 1:2 to receive either standard of care treatment or
      standard of care + Sertraline 200mg/day for 2 weeks, then 400 mg/day for 50 weeks for
      treatment of disseminated and meningeal coccidioidomycosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sertraline has been demonstrated to have in-vitro activity against coccidioides, and in-vivo
      activity against cryptococcal meningitis in clinical trials. Disseminated and meningeal
      coccidiodes infections require lifelong treatment, have poor outcomes, and new treatment
      options are needed. In this study the investigators will determine safety and tolerability of
      adjunctive sertraline (grade 4-5 adverse reactions) compared to standard coccidioidomycosis
      therapy alone.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse Reactions</measure>
    <time_frame>2 years</time_frame>
    <description>grade 4-5 adverse reactions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mycoses Study Group Score</measure>
    <time_frame>2 years</time_frame>
    <description>scoring of clinical outcomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression Screening</measure>
    <time_frame>2 years</time_frame>
    <description>Patient Health Questionnaire 9</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Assessment</measure>
    <time_frame>2 years</time_frame>
    <description>Karnofsky</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Coccidioidomycosis</condition>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard of care treatment for disseminated or meningeal coccidioidomycosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care + Sertraline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard of care treatment with the addition of sertraline for the treatment of disseminated or meningeal coccidioidomycosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sertraline</intervention_name>
    <description>400 mg/day sertraline</description>
    <arm_group_label>Standard of Care + Sertraline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe coccidioidomycosis infection, manifest as by one of:

               -  Coccidioidal meningitis;

               -  Severe pulmonary infection requiring intensive care unit level of care;

               -  Disseminated infection (in clinical opinion of the investigator); or

               -  Clinical progression after &gt;2 months of high dose fluconazole.

          -  Laboratory confirmation of Coccidioides infection by culture, histopathology,
             coccidioides polymerase chain reaction, positive complement fixation titer, or
             Coccidioides antigen

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Cannot or unlikely to attend regular clinic visits

          -  Presence of jaundice or known liver cirrhosis

          -  Pregnancy

               -  If there is a concern of pregnancy, a negative urine (or serum) pregnancy test
                  before study entry is required.

               -  Women of childbearing potential will have pregnancy test at enrollment and will
                  be recommended to use contraception and referred to family planning services as
                  necessary. (Refer to informed consent document.)

          -  Currently breastfeeding

          -  Active drug use (amphetamine or cocaine) or requirement for concomitant medications
             that raise the risk of serotonin syndrome

          -  Prolonged corrected QT interval or Left Bundle Branch Block on baseline
             electrocardiogram
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simon Paul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSF - Fresno</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Simon Paul, MD</last_name>
    <phone>559 435 3709</phone>
    <email>spaul@fresno.ucsf.edu</email>
  </overall_contact>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2016</study_first_submitted>
  <study_first_submitted_qc>September 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2016</study_first_posted>
  <last_update_submitted>September 16, 2016</last_update_submitted>
  <last_update_submitted_qc>September 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Simon Paul</investigator_full_name>
    <investigator_title>Professor of Clinical Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coccidioidomycosis</mesh_term>
    <mesh_term>Coccidiosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sertraline</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

